| 9. |
ACCRUED EXPENSES AND LONG-TERM LIABILITIES |
Other accrued expenses consisted
of the following as of March 31, 2020 and December 31, 2019:
| |
|
As Restated |
|
|
As Restated |
|
| |
|
March 31, 2020 |
|
|
December 31, 2019 |
|
| |
|
|
(unaudited) |
|
|
|
|
|
| Accrued royalties |
|
$ |
2,101 |
|
|
$ |
1,934 |
|
| Contingent consideration |
|
|
602 |
|
|
|
502 |
|
| Operating lease liability |
|
|
1,251 |
|
|
|
1,321 |
|
| Financing lease liability |
|
|
160 |
|
|
|
184 |
|
| Deferred revenue |
|
|
354 |
|
|
|
457 |
|
| Payable to CGI |
|
|
888 |
|
|
|
888 |
|
| Accrued sales and marketing - diagnostics |
|
|
167 |
|
|
|
197 |
|
| Accrued lab costs - diagnostics |
|
|
104 |
|
|
|
163 |
|
| Accrued professional fees |
|
|
1,064 |
|
|
|
1,399 |
|
| Taxes payable |
|
|
327 |
|
|
|
403 |
|
| Unclaimed property |
|
|
565 |
|
|
|
565 |
|
| All others |
|
|
1,056 |
|
|
|
1,463 |
|
| Total other accrued expenses |
|
$ |
8,639 |
|
|
$ |
9,476 |
|
Long-term liabilities consisted of
the following as of March 31, 2020 and December 31, 2019:
| |
|
March 31, 2020 |
|
December 31, 2019 |
| |
|
(unaudited) |
|
|
| Warrant liability |
|
$ |
55 |
|
|
$ |
82 |
|
| Uncertain tax positions |
|
|
4,146 |
|
|
|
4,081 |
|
| Deferred revenue |
|
|
258 |
|
|
|
269 |
|
| Other |
|
|
104 |
|
|
|
141 |
|
| Total other long-term liabilities |
|
$ |
4,563 |
|
|
$ |
4,573 |
|
|